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Bioactive glasses, especially silica-based materials, are reported to pres-
ent osteoconductive and osteoinductive properties, fundamental char-
acteristics in bone regeneration [1,2]. Additionally, dexamethasone
(Dex) is one of the bioactive agents able to induce the osteogenic differ-
entiation of mesenchymal stem cells by increasing the alkaline phos-
phatase activity, and the expression levels of Osteocalcin and Bone
Sialoprotein [3]. Herein, we synthesised silica (SiO2) nanoparticles
(that present inherent bioactivity and ability to act as a sustained drug
delivery system), and coated their surface using poly-L-lysine (PLL)
and hyaluronic acid (HA) using the layer-by-layer processing technique.
Further on, we studied the inﬂuence of these new SiO2-polyelectrolyte
coated nanoparticles as Dex sustained delivery systems. The SiO2
nanoparticles were loaded with Dex (SiO2-Dex) and coated with PLL
and HA (SiO2-Dex-PLL-HA). Their Dex release proﬁle was evaluated
and a more sustained release was obtained with the SiO2-Dex-PLL-HA.
All the particles were cultured with human bone marrow-derived mes-
enchymal stem cells (hBMSCs) under osteogenic differentiation culture
conditions. hBMSCs adhered, proliferated and differentiated towards
the osteogenic lineage in the presence of SiO2 (DLS 174nm), SiO2-Dex
(DLS 175nm) and SiO2-Dex-PLL-HA (DLS 679nm). The presence of
these materials induced the overexpression of osteogenic transcripts,
namely of Osteocalcin, Bone Sialoprotein and Runx2. Scanning Elec-
tron Microscopy/Electron Dispersive Spectroscopy analysis demon-
strated that hBMSCs synthesised calcium phosphates when cultured
with SiO2-Dex and SiO2-Dex-PLL-HA nanoparticles. These results indi-
cate the potential use of these SiO2-polyelectrolytes coated nanoparti-
cles as dexamethasone delivery systems capable of promoting
osteogenic differentiation of hBMSCs.
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Biomaterials based on nano-particles have gained increased attention
because of its potential application in several medical ﬁelds including
tissue engineering (TE), dentistry and pharmacy. We aim to study the
effects of nanoparticles suited for TE strategies on cells in vitro as well
as in vivo. Ostim! is a nano-hydroxyapatite aqueous paste approved for
clinical use as bone defect ﬁlling matrix. In a previous study in a bone
defect model, Ostim! showed to support bone formation with no
inﬂammatory reaction of the surrounding tissue [1]. Interestingly, the
addition of the paste on cultured cell in a typical cytotoxicity test set-up
resulted in a toxic effect in vitro. When exposing the cells to the parti-
cles in transwell-sytems, we were able to demonstrate that direct cell-
particle contact leads to cytotoxicity, which was further analyzed by
TEM. To optimize in vitro test systems for biomaterials to meet the in
vivo situation, we embedded cells either in ﬁbrin matrix prior to the
addition of the particles or placed the material between two layers of
viable human amnion. Subsequently, cell viability of the embedded
cells or the cells of the amniotic membrane was quantiﬁed. Placing the
paste between stretched amniotic layers showed results comparable to
the in vivo situation. This test system presents a promising candidate
for biomaterial evaluation.
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